Figure 2From: Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinomaThe expression of MMP-2 in clinical stage I and clinical stage III ovarian carcinoma. A, MMP-2 was weakly expressed in Clinical stage I ovarian carcinoma; B, MMP-2 was strongly expressed in clinical stage III ovarian carcinoma. [bar line = 50 μm].Back to article page